Closing soonClinical trial: Not allowed
CRI Irvington Postdoctoral Fellowship
Cancer Research Institute (CRI) · Nonprofit
Source: Cancer Research Institute (CRI) (curated) · View original posting ↗
Two standing deadlines per year: March 1 and September 1 (next: September 1, 2026).
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- Up to $243K
- DeadlineFinal application due date.
- Sep 1, 2026
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- —
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- —
- DurationMaximum project period for a single award.
- 3 yr
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- —
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- Recurring (annual)
- Open dateWhen applications open (or opened).
- —
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- $243K total
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Not allowed
Fellowship / trainingHigher educationNonprofit
Research areas
Basic mechanisms & biologyTherapeutics & drug discoveryTraining & career development
Auto-classified from the title and description (keyword-based) — may be imperfect.
Description
Three-year fellowships training the next generation of cancer immunologists and immunotherapy researchers: stipends of $74,000/$76,000/$78,000 plus a $5,000/year institutional allowance. No citizenship restriction. Curated entry; verify current terms at the program page.
This funder has no public API, so the entry is manually curated — confirm current amounts, deadlines, and eligibility on the source page.